Class II · Moderate risk
NADH/Carnitine/Taurine/B12
Lack of Assurance of Sterility
Is Carnitine recalled?
Yes — there is an active recall. 15 ongoing FDA recalls mention Carnitine (53 total). Check the affected lots below.
Recalls are matched by product description. A recall usually affects specific lots, not every package of Carnitine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Carnitine recalls on record
none so far in 2026; 53 on record, newest first
Class II · Moderate risk
Mic+b12
Lack of Assurance of Sterility
Class II · Moderate risk
Glutamine/Arginine/Carnitine 25 mg/100 mg/200 mg/mL Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
Carnitine-L 250 mg/mL Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
Lipo-Injection W/Methyl B12 500 Mcg/Carnitine/No Vit C W/Pres.
Lack of Assurance of Sterility
Class II · Moderate risk
Lipo-Boost W/Pres.
Lack of Assurance of Sterility
Class II · Moderate risk
L-Carnitine 500mg/Ml
Lack of Assurance of Sterility
Class II · Moderate risk
L-Carnitine 250mg/Ml
Lack of Assurance of Sterility
Class II · Moderate risk
L-Carnitine 50mg/Ml
Lack of Assurance of Sterility
Class II · Moderate risk
L-Carnitine 100mg/Ml
Lack of Assurance of Sterility
Class II · Moderate risk
Acetyl-L-Carnitine Injectable
Lack of Assurance of Sterility
Class II · Moderate risk
MIC-PLUS Carnitine Injectable
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Acetyl-L-Carnitine 500 mg/ml
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
Acetyl-L-Carnitine 250 mg/ml Injectable
Lack of Assurance of Sterility; FDA inspection identified GMP violations potentially impacting product quality and sterility
Class II · Moderate risk
L-Carnitine Injection USP 100 mg/ml
Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer
Class II · Moderate risk
Super MIC B Complex for L-Carnitine for Injection USP with Methylcobalamin 1000 mcg/ml
Marketed without an Approved NDA/ANDA; IM and SQ injectable products are being recalled because the manufacturing firm is not registered with the FDA as a drug manufacturer
Class II · Moderate risk
Levocarnitine Solution for injection
Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.
Class II · Moderate risk
Mic Plus B12
Lack of Assurance of Sterility: Lack of sterility assurance in compounded aseptically filled injectable products.
Class I · High risk
Esbelder Man Herbal Blend With L-Carnitine Dietary Supplement
Marketed Without an Approved NDA/ANDA: Products found to contain undeclared sibutramine, N-Desmethylsibutramine, and N-di- Desmethylsibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
Class I · High risk
Esbelin Siloutte Mezcal Herbal con L-Carnitine Suplemento Alimenticio
Marketed Without an Approved NDA/ANDA: Products found to contain undeclared sibutramine, N-Desmethylsibutramine, and N-di- Desmethylsibutramine. Sibutramine was removed from the U.S. market for safety reasons, making these products unapproved new drugs.
Class II · Moderate risk
Lipotropic 50ml w/L-Carnitine
The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
Class II · Moderate risk
Lipotropic 10ml with B-12 and L- Carnitine
The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
Class II · Moderate risk
Lipo C 30ml
The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
Class II · Moderate risk
L-Carnitine 30ml
The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
Class II · Moderate risk
Carnitine 250mg/ml
The firm received seven reports of adverse reactions in the form of skin abscesses potentially linked to compounded preservative-free methylprednisolone 80mg/ml 10 ml vials.
Free recall alerts
Know the day your medication is recalled
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.